Citigroup »

Pelthos Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Pelthos Therapeutics (PTHS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $21 1 21.00

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Pelthos Therapeutics

Murchinson
Ikarian Capital
Vanguard Capital Management
Boothbay Fund Management
J. Goldman & Co
Vanguard Group
Cantor Fitzgerald, L. P.
Diadema Partners
Knott David M Jr
Geode Capital Management
Vanguard Fiduciary Trust
Pale Fire Capital SE
Persistent Asset Partners
Steward Partners Investment Advisory
UBS Group

View all funds holding Pelthos Therapeutics